Apoptosis in the pathogenesis of cutaneous lupus erythematosus

American Journal of Dermatopathology

Volumn 20, Issue 3, 1998, Pages 233-241

  Chung, Jin Ho ^a   Kwon, Oh Sang ^a   Eun, Hee Chul ^a   Youn, Jai Il ^a   Song, Yeong Wook ^a   Kim, Joong Gon ^a   Cho, Kwang Hyun ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Apoptosis; Bcl 2; Cutaneous lupus erythematosus; Dermatomyositis; Ki 67; P53

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; DERMATOMYOSITIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KERATINOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS;

APOPTOSIS; CELL NUCLEUS; EPIDERMIS; GENETIC TECHNIQUES; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KI-67 ANTIGEN; LUPUS ERYTHEMATOSUS, CUTANEOUS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN; SKIN DISEASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0012196474     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199806000-00002     Document Type: Article

References (49)

1. Wyllie AH, Kerr JFR, Currie AR, Cell death: the significance of apoptosis, Int Rev Cytol 1980;68:251-306.
2. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease; a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
3. Norris DA, Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993;100:58S-68S.
4. Tan EM, Cohen AS, Fries IF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
5. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN, Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Arch Dermatol 1984;120:332-7.
6. Sontheimer RD, Thomas JR, Gilliam JN, Subacute cutaneous lupus erythematosus. Arch Dermatol 1979;115:1409-15.
7. Langley RGB, Walsh N, Nevill T, Thomas L, Rowden G. Apoptosis is the mode of keratinocyte death in cutaneous graft-versushost disease. J Am Acad Dermatol 1996;35:187-90.
8. Gilliam AC, Whitaker-Menezes D, Korngold R, Murphy GF. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol 1996;107:377-83.
9. Polakowska RR, Haake AR. Apoptosis: the skin from a new perspective. Cell Death Differ 1994;1:19-32.
10. Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993;101:107-12.
11. Paus R, Rosenbach T, Haas N, Czarnetzki BM. Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermaatol 1993;2:3-11.
12. Weedon D. Apoptosis. Adv Dermatol 1990;5:243-56.
13. Yóung AR. The sunburn cell. Photodematalogy 1987;4:127-34.
14. Compton MM, Cidlowsky JA, Rapid in vivo of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 1986;118:38-45.
15. Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy Immunol 1994;105:327-32.
16. Miyashita T, Reed JC. Bcl-2 transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 1992;52:5407-11.
17. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81: 151-7.
18. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993;74:609-19.
19. Milner J. The role of p53 in the normal control of cell proliferation. Curr Opin Cell Biol 1991;3:282-6.
20. Farmer G, Bargonetti J, Zhu H. Friedman P, Prywes R, Prives C. Wild-type p53 activates transcription in vitro. Nature 1992;358: 83-6.
21. Lane DP. p53, guardian of the genome. Nature 1992;358:15-6.
22. Lane DP. A in the life of p53. Nature 1993;362:786-7.
23. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
24. Swahney N, Hall PA. Ki67: structure, function, and new antibodies. J Pathol 1992;168:161-2.
25. Jerdan MS, Hood AF, Moore GW, Callen JP. Histopathologic comparison of the subsets of lupus erythematosus. Arch A Dermatol 1990;126:52-5.
26. Soini Y, Kamel D, Paakko P, Lehto VP, Oikarinen A, Vahakangas K. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Br J Dermatol 1994;131:514-20.
27. De Jong EMGJ, van Erp PEJ, Ruiter DJ, van de Kerkhof PCM. Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus. J Am Acad Dermatol 1991;25: 1032-8.
28. Tebbe B, Mazur L, Stadler R, Orfanos CE. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus: relation to immunopathological mechanisms. Br J Dermatol 1995;132:25-31.
29. Steinberg AD. Systemic lupus erythematosus: theories of pathogenesis and approach to therapy. Clin Immunol Immunopathol 1994;72:171-6.
30. Steinberg AD, Krieg AM, Gourley MF, Klinman DM. Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev 1990;118:129-63.
31. Lee LA, Norris DA, Weston WL. Neonatal lupus and the pathogenesis of cutaneous lupus. Pediatr Dermatol 1986;3:491-7.
32. Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol 1985;85:165s-75s.
33. Bielsa I, Herrero C, Collado A, Cobos A, Palou J, Mascaro M. Histopathologic findings in cutaneous lupus erythematosus. Arch Dermathol 1994;130:54-8.
34. Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA. Estradiol enhanced binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La: another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 1988; 141:1480-8.
35. Furukawa F, Kashihara SM, Lyon MB, Norris DA. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/ La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990;94:77-85.
36. Jones SK. The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions. Br J Dermatol 1992;126:554-60.
37. De la Brassine MF, Pierard GE. Cell renewal in discoid lupus erythematosus. J Cutan Pathol 1976;3:175-9.
38. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ. Growth suppression induced by wild-type p53 protein is accompanied by selective downregulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 1991;88:1958-62.
39. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;89:4495-9.
40. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
41. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive & negative modulators. Oncogene 1994;9:1807-12.
42. Selvakumaran M, Lin H-K, Miyashita T, et al. Immediate early up-regulation of bax expression by p53 but not TGFβI: a paradigm for distinct apoptotic pathways. Oncogene 1994;9:1791-8.
43. Fesus L, Davies PJA, Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell 1991;56:170-7.
44. Bianchi L, Farrace MG, Nini G, Piacentini M. Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin. J Invest Dermatol 1994;103:829-33.
45. Wyllie AH. Apoptosis: cell death in tissue regulation. J Pathol 1987;153:313-8.
46. Cohen JJ. Duke RC. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-93.
47. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, Nickoloff BJ. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am V Pathol 1995;146:1079-88.
48. Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis. Arch Dermatol 1968;97:640-50.
49. Lever WF, Schaumburg-Lever G. Connective tissue diseases. In: Lever WF, Schaumburg-Lever G, eds. Histopathology of the skin. 7th ed. Philadelphia: JB Lippincott, 1990:494-522.